Andrew C Wood

Andrew C Wood

UNVERIFIED PROFILE

Are you Andrew C Wood?   Register this Author

Register author
Andrew C Wood

Andrew C Wood

Publications by authors named "Andrew C Wood"

Are you Andrew C Wood?   Register this Author

12Publications

-Reads

Dual and Inhibition Demonstrates Synergy against Neuroblastoma.

Clin Cancer Res 2017 Jun 16;23(11):2856-2868. Epub 2016 Dec 16.

Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article
June 2017

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.

Cancer Cell 2014 Nov 10;26(5):682-94. Epub 2014 Nov 10.

Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Electronic address:

View Article
November 2014

Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program.

Pediatr Blood Cancer 2013 Nov 24;60(11):1860-7. Epub 2013 Jun 24.

Hematology-Oncology Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine and Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania.

View Article
November 2013

Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Clin Cancer Res 2013 Nov 17;19(22):6173-82. Epub 2013 Sep 17.

Authors' Affiliations: Division of Oncology and Center for Childhood Cancer Research; Division of Pathology, Children's Hospital of Philadelphia; Department of Pediatrics; Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.

View Article
November 2013